Company Monitoring Page for Amgen

latest headlines for company on cafepharma

Biotech Stock Mailbag: Best Stocks to Watch in '11
TheStreet.com
Fri, 01/7/11 - 07:21 am
Tags:
Oncothyreon, Xoma, Amarin, Opexa, Human Genome, Seattle Genetics, Vertex Pharmaceuticals, Merck, Dendreon, Biogen Idec, Amgen, Pharmasset
Drug Stocks Ended Mostly Lower (King Pharmaceuticals, AMGN, ARNA, XOMA)
Wall Street Bay
Sun, 01/2/11 - 12:24 pm
Tags:
King, Amgen, Arena Pharmaceuticals, Xoma
2011 Big-Cap Biotech Preview
TheStreet.com
Wed, 12/22/10 - 09:21 am
Tags:
biotech, Celgene, Amgen, Biogen Idec, Gilead Sciences, Genzyme, Sanofi
Drug Companies Stocks Underperfomed: AMGN, NVO, JNJ
Trader's Huddle
Sat, 12/18/10 - 12:44 pm
Tags:
Amgen, Novo Nordisk, JNJ
Amgen Drug Meets Primary Endpoint
Yahoo/Zacks
Sat, 12/18/10 - 12:35 pm
Tags:
Xgeva, Amgen, prostate cancer, Zometa
Amgen Celebration May be Premature
Minyanville
Tue, 12/14/10 - 09:46 pm
Tags:
Amgen, prostate cancer, Xgeva
Amgen shares rise after positive study data
Marketwatch
Tue, 12/14/10 - 11:11 am
Tags:
Amgen, prostate cancer, Xgeva
Amgen Drug Prevents Prostate Cancer From Spreading To Bone
Forbes
Mon, 12/13/10 - 09:14 pm
Tags:
Amgen, prostate cancer, Xgeva
Amgen, Actelion Talk but No Offer Made
TheStreet.com
Mon, 12/13/10 - 10:13 am
Tags:
Amgen, Actelion, M&A
Amgen Presents New XGEVA (Denosumab) Breast Cancer Skeletal-Related Event Prevention Data at SABCS
Yahoo/PR NewsWire
Sat, 12/11/10 - 11:41 am
Tags:
Amgen, denosumab, Xgeva, breast cancer
Actelion Wants to Remain Independent, CEO Clozel Says
Bloomberg
Sat, 12/11/10 - 10:49 am
Tags:
M&A, Amgen, Actelion
Pharmaceuticals Pregnant and Overdue
Seeking Alpha
Wed, 12/8/10 - 02:14 pm
Tags:
Abbott Laboratories, Amgen, Bristol-Myers Squibb, JNJ, Merck, Mylan, Pfizer
How Cheap Is Amgen's Stock by the Numbers?
Motley Fool
Sat, 12/4/10 - 12:20 pm
Tags:
Amgen, investors
The Amgen Sales Rep, The Doctor And The Dog
Pharmalot
Wed, 12/1/10 - 12:10 pm
Tags:
Amgen, drug reps, physicians
RNAi Is On Sale
Motley Fool
Tue, 11/30/10 - 10:52 am
Tags:
RNAi, Merck, Alnylam, Pfizer, Amgen, Novartis, Eli Lilly, Roche
Biotech Calendar: Key Dates for December
TheStreet.com
Tue, 11/30/10 - 09:20 am
Tags:
Delcath, Arena Pharmaceuticals, RXi Pharmaceuticals, Cell Therapeutics, Amgen, Incyte, Celgene, Corcept Therapeutics, Affymax, Targacept, Exelixis, Orexigen, ONYX Pharmaceuticals, Seattle Genetics, MannKind, Alimera, AstraZeneca, Human Genome Sciences
Actelion Takeover: Constant Speculation, Doubts Linger
Seeking Alpha
Mon, 11/29/10 - 09:04 am
Tags:
M&A, Abbott Laboratories, Actelion, GSK, JNJ, Roche, Amgen, Bristol-Myers Squibb
Amgen Holder Invesco Says Potential Actelion Deal Not `Hugely Compelling'
Bloomberg
Tue, 11/23/10 - 10:49 am
Tags:
Amgen, M&A, Actelion
Biotech's Biggest R&D Spenders 2010
Fierce Biotech
Mon, 11/22/10 - 10:45 am
Tags:
biotech, R&D, Amgen, Biogen Idec, Gilead Sciences, Genzyme, Celgene, Kyowa Hakko Kirin, Vertex Pharmaceuticals, Life Technologies, CSL, Amylin, Genmab, Cubist Pharmaceuticals, MannKind, companies, Merial
Actelion: Genzyme-Sanofi Redux?
WSJ Online
Mon, 11/22/10 - 10:32 am
Tags:
Genzyme, Actelion, Sanofi, M&A, Bayer, Amgen, AstraZeneca

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.